Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/171561
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Certain dietary interventions might improve the therapeutic index of cancer treatments. An alternative to the "drug plus diet" approach is the pharmacological reproduction of the metabolic traits of such diets. Here we explored the impact of adding metformin to an established therapeutic regimen on the systemic host metabolism of cancer patients. A panel of 11 serum metabolites including markers of mitochondria! function and intermediates/products of folate-dependent one-carbon metabolism were measured in paired baseline and post-treatment sera obtained from HER2-positive breast cancer patients randomized to receive either metformin combined with neoadjuvant chemotherapy and trastuzumab or an equivalent regimen without metformin. Metabolite profiles revealed a significant increase of the ketone body beta-hydroxybutyrate and of the TCA intermediate alpha-ketoglutarate in the metformin-containing arm. A significant relationship was found between the follow-up levels of homocysteine and the ability of treatment arms to achieve a pathological complete response (pCR). In the metformin-containing arm, patients with significant elevations of homocysteine tended to have a higher probability of pCR. The addition of metformin to an established anticancer therapeutic regimen causes a fasting-mimicking modification of systemic host metabolism. Circulating homocysteine could be explored as a clinical pharmacodynamic biomarker linking the antifolate-like activity of metformin and biological tumor response.
Matèries
Matèries (anglès)
Citació
Citació
CUYÀS, Elisabet, FERNÁNDEZ ARROYO, Salvador, BUXÓ, Maria, PERNAS, Sònia, DORCA, Joan, ÁLVAREZ, Isabel, MARTÍNEZ, Susana, PÉREZ GARCÍA, José manuel, BATISTA LÓPEZ, Norberto, RODRÍGUEZ SÁNCHEZ, César a., AMILLANO, Kepa, DOMÍNGUEZ, Severina, LUQUE, Maria, MORILLA, Idoia, STRADELLA, Agostina, VIÑAS, Gemma, CORTÉS, Javier, VERDURA, Sara, BRUNET, Joan, LÓPEZ BONET, Eugeni, GARCIA, Margarita, SAIDANI, Samiha, JOVEN, Jorge, MARTIN CASTILLO, Begoña, MENENDEZ, Javier a.. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients. _Aging-us_. 2019. Vol. 11, núm. 9, pàgs. 2874-2888. [consulta: 25 de febrer de 2026]. [Disponible a: https://hdl.handle.net/2445/171561]